Plocabulin, a tubulin inhibitor, presents antitumor activity in patient-derived xenograft (PDX) models of gastrointestinal stromal tumor (GIST)

被引：0
|
作者：
Wozniak, Agnieszka [1 ,2 ]
Wang, Yannick [1 ,2 ]
Wellens, Jasmien [1 ,2 ]
Gebreyohannes, Yemarshet K. [1 ,2 ]
Jose Guillen, Maria [3 ]
Galmarini, Carlos M. [3 ]
Aviles, Pablo M. [3 ]
Debiec-Rychter, Maria [1 ,2 ]
Sciot, Raf [1 ,2 ]
Schoffski, Patrick [1 ,2 ]
机构：
[1] Katholieke Univ Leuven, Leuven, Belgium
[2] Univ Hosp Leuven, Leuven, Belgium
[3] PharmaMar, Madrid, Spain
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3840
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3840
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
    Wang, Yannick
    Wozniak, Agnieszka
    Wellens, Jasmien
    Gebreyohannes, Yemarshet K.
    Guillen, Maria Jose
    Aviles, Pablo M.
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. TRANSLATIONAL ONCOLOGY, 2020, 13 (11):
  • [2] Plocabulin, a novel tubulin inhibitor, has antitumor activity in various patient-derived xenograft models of soft tissue sarcoma
    Wang, Yannick
    Wozniak, Agnieszka
    Cornillie, Jasmien
    Lee, Che-Jui
    Guillen, Maria Jose
    Aviles, Pablo
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [3] Robust activity of BLU-285, a potent and highly selective inhibitor of mutant KIT and PDGFRα, in patient-derived xenograft (PDX) models of gastrointestinal stromal tumor (GIST)
    Gebreyohannes, Yemarshet K.
    Wozniak, Agnieszka
    Zhai, Madelina-Elena
    Wellens, Jasmien
    Cornillie, Jasmien
    Evans, Erica
    Gardino, Alexandra K.
    Lengauer, Christoph
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2017, 77
  • [4] Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma
    Wang, Yannick
    Wozniak, Agnieszka
    Cornillie, Jasmien
    Aviles, Pablo
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [5] Anti-tumor effects of dovitinib in patient-derived gastrointestinal stromal tumor (GIST) xenograft models.
    Gebreyohannes, Yemarshet Kelemework
    Van Looy, Thomas
    Wozniak, Agnieszka
    Wellens, Jasmien
    Li, Haifu
    Cornillie, Jasmien
    Vanleeuw, Ulla
    Vreys, Lise
    Squires, Matthew
    Rodriguez, Ana-Maria
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Development of patient-derived xenograft (PDX) models for gastrointestinal stromal tumors (GIST) as a pre-clinical platform for drug development
    Ricono, Jill
    Mullins, Chelsea
    Nair, Praveen
    Mirsaidi, Cyrus
    Broudy, Thomas
    [J]. CANCER RESEARCH, 2015, 75
  • [7] Anti-tumor effects of dovitinib, a multi-target kinase inhibitor, in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
    Gebreyohannes, Yemarshet Kelemework
    Van Looy, Thomas
    Wozniak, Agnieszka
    Wellens, Jasmien
    Li, Haifu
    Cornillie, Jasmien
    Vanleeuw, Ulla
    Vreys, Lise
    Squires, Matthew
    Rodringuez, Ana-Maria
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2015, 75
  • [8] Anti-tumor effects of the novel KIT mutant inhibitor M4205 in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
    De Sutter, Luna
    Wozniak, Agnieszka
    Verreet, Jasper
    Vanleeuw, Ulla
    De Cock, Lore
    Linde, Nina
    Drechsler, Christine
    Esdar, Christina
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [9] UTILIZATION OF PATIENT-DERIVED TUMOR XENOGRAFT (PDX) MODELS IN ONCOLOGY
    Cybula, Magdalena
    Moxley, Katherine
    Wang, Lin
    Wang, Luyao
    Bieniasz, Magdalena
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (22) : 84 - 84
  • [10] Evaluation of tumor heterogeneity and therapeutic susceptibility in patient-derived xenograft (PDX) models of gastrointestinal tumors
    Kahl, T.
    Jenke, R.
    Koerfer, J.
    Lordick, F.
    Aigner, A.
    Buech, T.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 215 - 215
12345